SyedFarhanZafarMD

PubMed

• 56 citations
  Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases
  Ganji Purnachandra Nagaraju, Syed F. Zafar, Bassel F. El-Rayes
  Nutrition Reviews. 2013-08-01
• 31 citations
  Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...
  Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke
  The Lancet. Haematology. 2023-01-01
• 37 citations
  Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy
  Asfar S. Azmi, Philip A. Philip, Amro Aboukameel, Zhiwei Wang, Sanjeev Banerjee
  Current Cancer Drug Targets. 2010-05-01

Journal Articles

• Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer  
  Ronan J Kelly 1, Jaffer A Ajani 1, Jaroslaw Kuzdzal 1, Thomas Zander 1, Eric Van Cutsem 1, Guillaume Piessen 1, Guillermo Mendez 1, Josephine Feliciano 1, Satoru Motoy..., N Engl J Med . 2021 Apr 1;384(13):1191-1203, 4/1/2021
• Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-...  
  Kundranda M, Gracian AC, Zafar SF et al, ANN Oncol. 2020 Jan;31(1):79-87. doi: 10.1016/j.annonc.2019.09.004, 1/31/2020

Abstracts/Posters

• Phase 2 Study of Zanubrutinib in Patients with Relapsed/Refractory B-Cell Malignancies Intolerant to Ibrutinib/Acalabrutinib
  azyar Shadman, MD, MPH1*, Jeff P Sharman, MD2, Moshe Y. Levy, MD3, Jamal Misleh, MD4*, Syed F. Zafar, MD5, Benjamin B. Freeman, MD6*, John M. Burke, MD7, Jennifer L. C..., ASH- Session: 623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Poster III Hematology Disease Topics & Pathways, ASH/Blood
• Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymp...
  ohn G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath1, Wojciech Jurczak, MD, PhD2, Ryan Jacobs, MD3, Sebastian Grosicki, MD, PhD4, Krzysztof Giannopoulos, MD, PhD5, Tomasz ..., American Society of Hematology/ Blood